Connect with us

Technology

Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series

Published

on

Evolution of Ferment conference to kick off Summer 2025

BOSTON, Feb. 6, 2025 /PRNewswire/ — Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the 2025 Ferment Series, an evolution of its flagship annual conference dedicated to advancing Ginkgo’s mission of making biology easier to engineer. Throughout 2025, Ginkgo product teams will hold a series of focused Ferments at Ginkgo’s beautiful event venue, located at 19 Fid Kennedy Ave in Boston’s historic Seaport District, just a five-minute walk from Ginkgo’s headquarters.

Each Ferment in the 2025 series will dive deep into specific focus areas—spanning Ginkgo’s cell engineering and biosecurity offerings—and highlight how Ginkgo’s broad horizontal platform for engineering biology is enabling transformative solutions across markets including pharma & biotech, agriculture, industrial biotech, government, and beyond. Speawkers and panelists will include Ginkgo experts, partners, and industry leaders who are applying engineered biology to discover, optimize, and manufacture cutting-edge products.

Attendees will also get a close look at Ginkgo’s technologies and the innovations they have delivered to partners around the world. In addition, entirely new products and next-generation services will be showcased, including Ginkgo Datapoints’ high-throughput AI-driven data generation services; Ginkgo Automation’s Reconfigurable Automation Cart (RAC) systems; and Ginkgo Biosecurity’s product suite anchored by Canopy (persistent, environmental pathogen monitoring) and Horizon (data-driven global threat intelligence).

“We made big changes in 2024, and our mission is stronger than ever,” said Jason Kelly, co-founder and CEO of Ginkgo Bioworks. “Whether you’re seeking the perfect antibody, looking to spin up a data generation engine to train your biological AI model, outfitting your lab with extensible and flexible automation, or building a new biosecurity solution to meet your mission’s demands, you can find your needle in our tech stack. We’re excited to show how the platform is evolving, and our new automation capabilities, expanded AI offerings, and next-gen data services will all be on full display at our 2025 Ferment event series. Join us as we celebrate the transformative power of biology and the foundational advancements being made by pioneers across our industry.”

A larger, platform-wide Ferment will return in 2026, alternating years with targeted business-specific gatherings.

2025 Ferment Series Calendar

Summer: Datapoints x AI
Ginkgo Datapoints generates high-quality data at the scale, price, and speed you need. Learn more about our new data-generation services (Functional Genomics & Antibody Developability) and dive into the AI models that we’re deploying and leveraging to accelerate biotech R&D.September: Ginkgo Biopharma Solutions
Ginkgo Biopharma Solutions partners to accelerate your preclinical drug discovery and development research with cutting-edge automation, AI-driven tools, and world-class scientific expertise. Our solutions and products streamline research, enhance efficiency, and empower drug developers to push the boundaries of innovation. Join us to explore our latest offerings and see how our teams help bring therapeutics from concept to clinic.October: Biosecurity
Exploring the future of biosecurity. Experts from government and industry will discuss strategies for identifying, monitoring, and mitigating biological risks.November: Automation
Demonstrations of Ginkgo’s RAC Automation systems, plus in-depth tours of the Foundry to illustrate how large-scale data generation and new automation tech are fueling breakthroughs in cell programming.

Dates are subject to change.

Ginkgo’s Agriculture team is especially excited to meet with partners, old and new, at World AgriTech in San Francisco (March) and ABIM (October), in addition to other industry conferences. As a Gold Sponsor of World AgriTech SF, Ginkgo will be hosting a tour of its R&D facility in West Sacramento, CA on March 10, 2025. Find out more about that pre-summit tour here.

Connect with fellow innovators and leaders, and develop the relationships and ideas that will shape the future of biotechnology. For more information about Ginkgo’s 2025 Ferment series and to subscribe to updates, please visit our series home page, 

About Ginkgo Bioworks:
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn.

GINKGO BIOWORKS INVESTOR CONTACT:
investors@ginkgobioworks.com

GINKGO BIOWORKS MEDIA CONTACT:
press@ginkgobioworks.com

Forward-Looking Statements of Ginkgo Bioworks
This press release contains certain forward-looking statements within the meaning of the federal securities laws, including statements regarding the capabilities and potential success of Ginkgo’s cell engineering and biosecurity offerings. These forward-looking statements generally are identified by the words “believe,” “can,” “project,” “potential,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: (i) volatility in the price of Ginkgo’s securities due to a variety of factors, including changes in the competitive and highly regulated industries in which Ginkgo operates and plans to operate, variations in performance across competitors, and changes in laws and regulations affecting Ginkgo’s business, (ii) the ability to implement business plans, forecasts, and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry, including due to advancements in technology, emerging competition and evolution in industry demands, standards and regulations, (vi) the outcome of any pending or potential legal proceedings against Ginkgo, (vii) our ability to realize the expected benefits from and the success of our Foundry platform programs, (viii) our ability to successfully develop engineered cells, bioprocesses, data packages or other deliverables, and (ix) the product development or commercialization success of our customers. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of Ginkgo’s annual report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on February 29, 2024, Ginkgo’s most recent quarterly report on Form 10-Q, and other documents filed by Ginkgo from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Ginkgo assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Ginkgo does not give any assurance that it will achieve its expectations.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-to-host-6th-annual-ferment-as-boston-based-conference-series-302370156.html

SOURCE Ginkgo Bioworks

Continue Reading

Technology

Legrand Launches Starline T5 DoubleBar, the Highest Ampacity Open-Channel Track Busway with Most Pluggable Space

Published

on

By

WEST HARTFORD, Conn., Oct. 20, 2026 /PRNewswire/ — Legrand, the global specialist in electrical and digital building infrastructures, today launched the Starline T5 DoubleBar track busway. Engineered specifically for high-density environments, the T5 DoubleBar offers the highest ampacity open-channel busway available on the market with the most pluggable space, addressing the exponential power demands of artificial intelligence and high-performance computing.

By featuring a configuration with two T5 bars in parallel, the system delivers up to 2000A, enabling robust power distribution for high-density environments. This hybrid busway design successfully combines open-channel flexibility with busduct-level ampacity for maximum adaptability.

“As AI workloads push rack densities past 100kW, data center operators have been forced into a clear trade-off: install heavy, rigid busducts to get high amperage, or use track busways to maintain operational flexibility,” said Mark Swift, Vice President of Engineering for Starline, a brand of Legrand. “With the T5 DoubleBar, we’ve completely eliminated that compromise. By delivering 2000A in a continuous open-channel architecture, we give operators the raw power density of a traditional busduct without forcing them to clutter their white space with redundant  busway runs or sacrifice the agility to reconfigure on the fly.”

Key Features and Benefits of the Starline T5 DoubleBar

The T5 DoubleBar eliminates spacing constraints common in traditional busduct systems and minimizes the whitespace footprint in dense data center layouts.

Unmatched AI & HPC Support: The system handles rack loads up to 150kW, meeting next-gen data center demands. It is also compatible with LVDC installations to 1000VDC.Increased Pluggable Space: The high-density double-bar architecture utilizes parallel conductors to increase amperage and pluggable space without increasing the system’s footprint.Zero-Downtime Reconfiguration: Hot-pluggable tap-off capability allows for the safe, live installation and removal of tap-off units without a system shutdown, maximizing operational continuity.True Modularity and Scalability: The modular design supports multiple ratings without system redesign. Furthermore, it is designed for future expansion up to 5000A, protecting long-term capital investments.Complete T5 Ecosystem Compatibility: The system maintains open-channel plug-in access and full compatibility with all existing T5 plug-in units.

Launching Alongside High-Capacity Plug-in Unit (HCP)

To complete this end-to-end high-density power distribution system, Legrand is simultaneously launching a new High-Capacity Plug-in Unit (HCP) designed for seamless integration directly on T5 infrastructure, including the new DoubleBar.

These new plug-in units offer up to 250A capacity and multiple enclosure formats, delivering more power through a single unit. By powering high-density AI and HPC racks directly, the HCP reduces the need for multiple lower-amperage plug-ins, simplifying the overall power delivery architecture.

For more information on the Starline T5 DoubleBar and High-Capacity Plug-in Units, visit the Starline website.

About Legrand:

Legrand is the global specialist in electrical and digital building infrastructures. Its comprehensive offering of solutions for residential, commercial, and datacenter markets makes it a benchmark for customers worldwide. The Group harnesses technological and societal trends with lasting impacts on buildings with the purpose of improving life by transforming the spaces where people live, work and meet with electrical, digital infrastructures and connected solutions that are simple, innovative and sustainable. Drawing on an approach that involves all teams and stakeholders, Legrand is pursuing a strategy of profitable and responsible growth driven by acquisitions and innovation, with a steady flow of new offerings that include products with enhanced value in use. Legrand reported sales of €9.5 billion in 2025. The company is listed on Euronext Paris and is a component stock of the CAC 40, CAC 40 ESG and CAC Transition Climat indexes (code ISIN FR0010307819). www.legrand.us

Media Contact:

Jaymie Scotto & Associates
+1 866.695.3629 ext. 19
jsa_legrand@jsa.net

View original content to download multimedia:https://www.prnewswire.com/news-releases/legrand-launches-starline-t5-doublebar-the-highest-ampacity-open-channel-track-busway-with-most-pluggable-space-302914273.html

SOURCE Legrand DPC LLC

Continue Reading

Technology

Trinity Acquires Verix, Adding AI-Powered Next-Best-Action and Omnichannel Orchestration to the TrinityEDGE Platform

Published

on

By

Verix’s patented Tovana™ platform and its full team join Trinity, extending TrinityEDGE™ from what commercial teams know into what they do next

WALTHAM, Mass., Oct. 20, 2026 /PRNewswire/ — Trinity, the leader in integrating human and artificial intelligence for life sciences commercialization, today announced it has acquired Verix, the pharma-native commercial intelligence company behind the patented, AI-powered Tovana™ platform. Tovana is live today in global pharma, biotech, and specialty pharma commercial organizations, where it turns prescription, claims, clinical, and engagement data into continuous next-best-action, dynamic targeting, and omnichannel orchestration for brand, field, and digital teams. The acquisition brings Verix’s entire team into Trinity and adds an AI execution layer to TrinityEDGE. Terms were not disclosed.

Why now

Pharma has already bought AI but has not yet realized the pay off. Trinity’s 2025 Commercial and Medical IT benchmark found that 100 percent of surveyed organizations had adopted generative AI in some capacity, yet innovation confidence averaged just 3 out of 5, and every respondent described their organization as only somewhat prepared to respond rapidly to industry change. A separate Trinity benchmark of new product planning and commercial strategy leaders found only 10 percent had a clear AI strategy they were scaling across workflows. Adoption is universal yet impact is not.

The reason is rarely the model. It is the distance between an insight and the moment someone acts on it. Targeting lists go stale between planning cycles. Omnichannel plans degrade. Next-best-action tools get ignored because reps cannot see why they should trust them. Brands pay twice, once for insight and again for a separate execution vendor, and still struggle to show impact. Closing that insight-to-action loop is the problem TrinityEDGE with Tovana will solve.

The acquisition also advances Trinity’s growth strategy. Over the past three years Trinity has augmented its advisory and insights services with the TrinityEDGE productized commercialization platform, adding software, data, and AI alongside 1,500 professionals in 14 offices on five continents. Verix deepens Trinity’s presence with the brand, field, and digital buyers who sit beyond its traditional strategy and insights relationships, and establishes a dedicated AI and product development center to build and ship commercial AI at scale.

Proof, not promise

Tovana is not a new build. It has been developed and validated in live pharmaceutical and biotech deployments since 2007, across large global pharma, mid-size biotech, and specialty and rare disease organizations.

Deployed at scale in oncology and specialty markets. Tovana supports commercial teams at global pharmaceutical companies and emerging biotechs, including publicly referenced work and support for the U.S. launch of a targeted oncology immunotherapy in a market its sponsor estimates at more than $400 million.

Measured commercial lift. One of the largest pharmaceutical oncology divisions in the United States increased leading KPIs, including new prescriptions, by 15 to 25 percent with Tovana. A rare oncology therapy team improved field-facing NPS by 12x.. A medical device commercial team improved sales outcomes within three months of implementation.

Time to value measured in weeks. Tovana’s pharma-specific data foundation, automated data pipelines, and pre-built model toolkit mean clients adopt targeting and engagement models already proven in live deployments, with rapid configuration and deployment inside a single planning cycle.

What clients get

A plan that holds up between quarters. Targeting, segmentation, and channel mix update against what the market is actually doing, so the engagement plan approved in January is still the plan operating in June.

Guidance the field will actually use. Recommendations arrive sourced and explainable, grounded in Trinity’s therapeutic, launch, and benchmarking depth, and delivered inside the field workflow through FieldAdvisor. That is the difference between a next-best-action a rep follows and one a rep ignores.

One partner instead of two. Existing Trinity clients get a path from insight they already own to execution, without standing up another vendor or rebuilding integrations. Existing Verix clients keep the product, roadmap, and support they rely on, and gain Trinity’s launch, market access, and competitive benchmarking context.

Tovana capabilities will be progressively integrated into the TrinityEDGE single sign-on environment over the coming months, strengthening CustomerEDGE™ execution, with the first joint offerings expected to reach clients in 1H 2027. Verix CEO Doron Aspitz joins Trinity’s leadership team and will continue to guide the Tovana roadmap.

Leadership perspective

“Every commercial leader I meet is asking how to put AI to work where it actually changes a call, a channel mix, or a forecast,” said Scott Evangelista, Chief Executive Officer of Trinity. “Insight has outpaced execution. Teams are rich in disparate analysis and thin in decisive action in front of a customer. Verix closes that gap. Next-best-action, dynamic targeting, and omnichannel orchestration now sit inside TrinityEDGE, proven in live pharma deployments and backed by 30 years of therapeutic and commercial judgment. That is what it means to lead in integrating human and artificial intelligence for life sciences commercialization.”

“We built Verix on one conviction: commercial teams deserve intelligence that is timely, explainable, and usable in the flow of work,” said Doron Aspitz, Chief Executive Officer of Verix. “Joining Trinity is the natural next step. Clients keep the product they rely on and gain the launch, access, and competitive context that tells them whether performance is genuinely competitive. I am proud of what our teams have built and energized by what we can now build together.”

About Verix

Verix is a leading provider of advanced commercial optimization solutions for the life sciences industry. Its flagship product, Tovana™, is a patented, AI-powered SaaS platform that enables life sciences companies to optimize commercial strategy and execution. Tovana integrates advanced machine learning, agentic workflows, and deep domain expertise into a single, intuitive platform, supporting dynamic targeting and segmentation, next best action, omnichannel orchestration, patient discovery, therapeutic landscape analysis, opportunity assessment, and bottom-up forecasting. Founded in 2007, Verix serves pharmaceutical, biotech, and specialty pharma commercial organizations from offices in the United States and Israel.

About Trinity

Trinity is a life sciences commercialization company that combines deep therapeutic, functional, and commercial expertise with AI-powered platforms. For more than 30 years, pharmaceutical, biotech, and medtech companies have relied on Trinity to connect strategy, data, and execution—supporting better decisions, more confident launches, and sustained commercial performance. Trinity helps clients turn insight into action and bring innovations to market with greater speed and confidence. Learn more at trinitylifesciences.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/trinity-acquires-verix-adding-ai-powered-next-best-action-and-omnichannel-orchestration-to-the-trinityedge-platform-302914278.html

SOURCE Trinity

Continue Reading

Technology

Baker Hill Launches $10,000 Battle of OKC Pitch Competition for Veteran Entrepreneurs

Published

on

By

New competition brings Baker Hill, The Verge OKC, IVMF, Gradient, and Oklahoma SBDC together to support Oklahoma veterans as they build and grow businesses

OKLAHOMA CITY, Oct. 20, 2026 /PRNewswire/ — Oklahoma veteran entrepreneurs will have the opportunity to compete for $10,000, showcase their businesses and connect with resources to help them grow through Battle of OKC, a new business pitch competition culminating live on Veterans Day in Oklahoma City.

Baker Hill today announced the competition in collaboration with The Verge OKC and the Institute for Veterans and Military Families (IVMF), Gradient and Oklahoma SBDC. Battle of OKC will bring veteran entrepreneurs together with business leaders, mentors and community resources while giving them a platform to put their ideas and businesses in the spotlight.

“Veterans know how to lead, adapt and find a way forward when the path isn’t obvious — the same qualities it takes to build a business,” said Andy Ivankovich, chairman and CEO of Baker Hill. “Battle of OKC is about putting opportunity behind that potential. We want to give veteran entrepreneurs a platform to tell their stories, connect with people and resources that can help them grow and compete for capital that can make a meaningful difference in what comes next.”

Battle of OKC is open Veteran entrepreneurs whose business is majority veteran-owned, has operated for at least one year, and is registered in Oklahoma. Applicants will begin by submitting a three-minute video introducing their business, the opportunity they see and why they are ready to take the next step. A panel will select 10 entrepreneurs to advance to finals.

Ten finalists will then advance to the live Battle of OKC on Veterans Day, Wednesday, Nov. 11, at the Verge in Oklahoma City, where they will pitch before a panel of judges and compete for a $10,000 grand prize.

The Verge OKC, a nonprofit community that helps turn ideas into impactful businesses, will help recruit and coach participating entrepreneurs throughout the competition.

“The Verge is all about connecting entrepreneurs with the people, resources, and opportunities they need to turn their ideas into thriving businesses”, said Kristin Garcia, Executive Director. “We’re excited to be part of Battle of OKC and to purposefully create space for our military community to engage with Oklahoma’s entrepreneurial ecosystem. Veterans bring valuable skills, leadership, and unique perspectives to business ownership, and they deserve to know there’s a community here ready to support them as they build and grow their businesses.”

The D’Aniello Institute for Veterans and Military Families (IVMF), will provide support outreach and recruitment/connect participating veterans with entrepreneurship resources/provide expertise.

“Just last month, we brought together veteran entrepreneurs, business leaders, and community partners in Oklahoma City for the Military Entrepreneurship Forum. Battle of OKC is a great example of how that momentum continues, with the community coming together to recognize, celebrate, and invest in Oklahoma’s veteran-owned businesses, said Barbara E. Carson, Managing Director, Programs and Policy. D’Aniello Institute for Veterans and Military Families. “At the D’Aniello IVMF, we know that when veteran entrepreneurs have access to the right networks, resources, and opportunities, they can build thriving businesses that strengthen their communities.”

Oklahoma SBDC will also provide recruitment and pitch coaching for the finalists the week of the event. “This collaboration brings together partners with complementary expertise to support Oklahoma’s veteran business owners,” said Dr. Michele Hockersmith, state director of the Oklahoma SBDC. “Our role is to help entrepreneurs connect their pitch to a sound business strategy, with clear financials and realistic growth plans. That preparation has value for the competition and beyond.”

Battle of OKC is designed to provide more than a stage and a prize. By bringing together veteran entrepreneurs, business leaders and organizations committed to supporting entrepreneurship, the competition creates connections and access to expertise that can continue well beyond the final pitch.

Veteran entrepreneurs interested in competing can learn more about eligibility and submit their three-minute video pitch at www.bakerhill.com/okc. Applications close October 29. Ten finalists will be selected to compete live in Oklahoma City on Veterans Day.

About Baker Hill
Baker Hill is the leading provider of commercial lending technology for banks and credit unions across the United States. Each month, financial institutions use Baker Hill’s platform to process more than $7 billion in lending originations — helping them Lend Better, Lend Faster, and Lend More™ in their communities. Backed by Flexpoint Ford, a private equity firm, Baker Hill delivers the scale, security and innovation required to meet the demands of modern banking. The company is headquartered in Carmel, Indiana, with operations in Santa Barbara, California. For more information, visit www.bakerhill.com.

About The Verge OKC
The Verge OKC, a 501(c)(3) nonprofit community that helps turn ideas into impactful businesses, will help recruit and coach participating entrepreneurs throughout the competition. Learn more: https://www.vergeokc.com 

About the D’Aniello Institute for Veterans and Military Families
The IVMF at Syracuse University is higher education’s first interdisciplinary academic institute, singularly focused on advancing the post-service lives of the nation’s military veterans and their families to serve those who have served. Learn more: https://ivmf.syracuse.edu 

About Oklahoma SBDC
The Oklahoma Small Business Development Center (Oklahoma SBDC) provides confidential, no-cost business advising, training and market research to help entrepreneurs start and grow businesses statewide. Hosted by Southeastern Oklahoma State University, the state-wide network helps business owners strengthen financial plans, prepare for financing and pursue growth opportunities. Learn more at www.oksbdc.org.

About Gradient
Gradient represents the blending of diverse ideas, people, and perspectives, adding texture and depth to our community. As one of the nation’s largest innovation hubs, Gradient fosters meaningful connections, nurtures bold ideas, and provides concierge introductions to entrepreneurial resources. Learn more at www.joingradient.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/baker-hill-launches-10-000-battle-of-okc-pitch-competition-for-veteran-entrepreneurs-302914275.html

SOURCE Baker Hill

Continue Reading

Trending